ARTICLE | Clinical News
Infanrix DTaP-HepB-IPV regulatory update
March 12, 2001 8:00 AM UTC
The FDA's Vaccine and Related Biological Products Advisory Committee recommended 6-5, with one abstension, against approval of GSK's Infanrix DTaP-HepB-IPV to prevent diphtheria, tetanus, pertussis, h...